Kulkarni Sayali P, Paliwal Shruti, Kosta Susmit
Obstetrics and Gynaecology, Sri Aurobindo Institute of Medical Sciences, Indore, IND.
Molecular and Virology Research Diagnostic Lab, Sri Aurobindo Institute of Medical Sciences, Indore, IND.
Cureus. 2023 Feb 20;15(2):e35227. doi: 10.7759/cureus.35227. eCollection 2023 Feb.
Background The high-risk human papillomavirus (hr-HPV) is linked with cervical cancer (CC), and the distinct proportional impact of each genotype on the prevalence of the disease depends on the area. Therefore, to find out the prevalence of HPV types in women with cervical lesions from central India, the current study was performed. Methodology Age, prior history of cervical disease, changes in lifestyle characteristics, menopausal status, and HPV vaccination status were all carefully gathered at enrollment for the 736 women (aged 21 to 60) screened in this cross-sectional study who were referred for regular screening of cervical during the study period. Cervix was examined for lesions by visual inspection with acetic acid (VIA) screening and HPV genotypes were identified by real-time polymerase chain reaction (RT-PCR). Result Among 736 women 215 (29.2%) were in the 21-30 age group, 321 (43.6%) in the 31-40 age group, 132 (17.9%) in the 41-50 age group, and 68 (9.3%) cases in >50 age group. According to education, there were 398 (54.1 %) with primary and below education, 115 (15.6%) with secondary education, and 223 (30.3%) with college and above education. HPV-16, 18, 31, and 45 each had a prevalence of 29.6%, 11.1%, 12.9%, and 9.2%, respectively, while the overall prevalence of hr-HP) was present in populations at 7.3% in individuals and 37.0% in combinations. Hr-HPV infection and prevalence were provocatively more (79.6%) in the VIA-positivity rate with CC. Conclusion Individual hr-HPV genotype prevalence was shown to be lower than with combinations (HPV-16, 18, 31, and 45). The HPV-16 genotype was identified to have a higher prevalence than HPV-18, 31, and 45. However, more awareness programs are needed for a better understanding of CC and HPV testing in central India.
背景 高危型人乳头瘤病毒(hr-HPV)与宫颈癌(CC)相关,每种基因型对该疾病患病率的不同比例影响因地区而异。因此,为了了解印度中部宫颈病变女性中HPV各型别的患病率,开展了本研究。
方法 在这项横断面研究中,对736名年龄在21至60岁之间、在研究期间被转诊进行宫颈定期筛查的女性进行登记时,仔细收集了她们的年龄、宫颈疾病既往史、生活方式特征变化、绝经状态和HPV疫苗接种状况。通过醋酸肉眼观察法(VIA)筛查宫颈病变,并通过实时聚合酶链反应(RT-PCR)鉴定HPV基因型。
结果 736名女性中,215名(29.2%)在21 - 30岁年龄组,321名(43.6%)在31 - 40岁年龄组,132名(17.9%)在41 - 50岁年龄组,68名(9.3%)在50岁以上年龄组。按教育程度划分,小学及以下学历者398名(54.1%),初中学历者115名(15.6%),大专及以上学历者223名(30.3%)。HPV-16、18、31和45型的患病率分别为29.6%、11.1%、12.9%和9.2%,而hr-HPV的总体患病率在个体中为7.3%,在合并感染中为37.0%。在伴有CC的VIA阳性率中,hr-HPV感染和患病率明显更高(79.6%)。
结论 单个hr-HPV基因型的患病率低于合并感染(HPV-16、18、31和45型)。已确定HPV-16基因型的患病率高于HPV-18、31和45型。然而,在印度中部,需要开展更多的宣传项目,以更好地了解宫颈癌和HPV检测。